Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial
出版年份 2012 全文链接
标题
Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial
作者
关键词
-
出版物
BLOOD
Volume 120, Issue 16, Pages 3280-3287
出版商
American Society of Hematology
发表日期
2012-09-05
DOI
10.1182/blood-2012-04-421057
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma
- (2012) Jonathan A Harris et al. Diagnostic Pathology
- Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma
- (2012) B. Sanchez-Espiridion et al. HAEMATOLOGICA
- International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era
- (2012) Alden A. Moccia et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of FOXP3, CD68, and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma Is Predictive of Outcome
- (2012) Paul Greaves et al. JOURNAL OF CLINICAL ONCOLOGY
- Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma
- (2011) D. Azambuja et al. ANNALS OF ONCOLOGY
- Transcriptomic analyses of murine resolution-phase macrophages
- (2011) M. J. Stables et al. BLOOD
- Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
- (2011) P. Allavena et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The Viral Load of Epstein-Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma
- (2011) S. Hohaus et al. CLINICAL CANCER RESEARCH
- CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma
- (2011) Dok Hyun Yoon et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Cancer-promoting tumor-associated macrophages: New vistas and open questions
- (2011) Alberto Mantovani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Macrophages predict treatment outcome in Hodgkin's lymphoma
- (2011) C. Steidl et al. HAEMATOLOGICA
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
- (2011) Christian Steidl et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic validation of specific phenotypic markers for in vitro polarized human macrophages
- (2011) C.A. Ambarus et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Identification and manipulation of tumor associated macrophages in human cancers
- (2011) Moniek Heusinkveld et al. Journal of Translational Medicine
- The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma
- (2011) Ljubomir R. Jakovic et al. LEUKEMIA & LYMPHOMA
- Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series
- (2011) Pablo Guisado-Vasco et al. LEUKEMIA & LYMPHOMA
- Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma
- (2011) Alexandar Tzankov et al. PATHOBIOLOGY
- Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma
- (2011) Mona A. A. Zaki et al. VIRCHOWS ARCHIV
- Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma
- (2010) P. Kamper et al. HAEMATOLOGICA
- Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy
- (2010) Hanne Van Gorp et al. MOLECULAR IMMUNOLOGY
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
- (2010) Christian Steidl et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started